GlassScriptPrepare for your visit
Rohan Mehta
Rheumatology · Willow Grove, PA · NPI 1760944656
One page to bring to your appointment. Every figure is as reported to CMS by drug and device makers. Payments are legal and often routine; this is context for a conversation, not a verdict.
What was reported
$4,325.21
in general payments reported to CMS, 2019-2025 · $3,833 in 2025
The $3,833 reported for 2025 was more than what 82% of Rheumatology providers received nationally (typical 2025 total: $894).
Who reported paying
General payments only, top 6 by amount.
- Amgen INC. $917.90
- Abbvie INC. $531.82
- Astrazeneca Pharmaceuticals LP $432.50
- Janssen Biotech, INC. $350.26
- Ucb, INC. $344.02
- Ani Pharmaceuticals, INC. $225.42
Drugs and devices associated with these payments
Rinvoq Saphnelo Prolia Tremfya Bimzelx Evenity Purified Cortrophin Gel Tymlos Cosentyx Xeljanz Hadlima Taltz
Association is not allocation: a product listed here means a payment was associated with it, not that money was paid to promote it. Detail covers 2023-2025.
Questions you might ask
- I saw Rohan Mehta listed in the CMS Open Payments database. Can you tell me about your work with those companies?
- Is there a generic or alternative to this medication, and would it work as well for me?
- What made you choose this particular treatment for my situation?
These are normal questions. A good clinician will welcome them.
Notes
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.
GlassScript is independent and not affiliated with CMS or any government agency. glasscript.com/doctor/11627863/rohan-mehta